Private Advisor Group’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,084
Closed -$35.9K 2707
2025
Q4
$35.9K Sell
2,084
-55
-3% -$1.07K ﹤0.01% 2536
2025
Q3
$55.1K Hold
2,139
﹤0.01% 2448
2025
Q2
$123K Buy
2,139
+9
+0.4% +$722 ﹤0.01% 2297
2025
Q1
$231K Buy
2,130
+709
+50% +$61.7K ﹤0.01% 2027
2024
Q4
$67.5K Sell
1,421
-117
-8% -$7.07K ﹤0.01% 2203
2024
Q3
$151K Buy
1,538
+94
+7% +$12.1K ﹤0.01% 2266
2024
Q2
$236K Buy
1,444
+26
+2% +$3.7K ﹤0.01% 2050
2024
Q1
$216K Buy
1,418
+8
+0.6% +$1.33K ﹤0.01% 2066
2023
Q4
$442K Buy
1,410
+4
+0.3% +$1.45K ﹤0.01% 1556
2023
Q3
$624K Sell
1,406
-1
-0.1% -$452 0.01% 1279
2023
Q2
$610K Buy
+1,407
New +$791K 0.01% 1282

Other funds holding AGL

Private Advisor Group's AGL Position: Q1 2026 in Review

Private Advisor Group sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 2,084 shares — an estimated $35.9K sold.

Private Advisor Group first reported a position in AGL in Q2 2023 and held it in 11 quarters. The position peaked at $624K in Q3 2023. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Private Advisor Group reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • Private Advisor Group sold 2,084 Agilon Health shares in Q1 2026, an estimated $35.9K.
  • Private Advisor Group first reported a position in Agilon Health in Q2 2023 and held it in 11 quarters.
  • Private Advisor Group's Agilon Health position peaked at $624K in Q3 2023.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.